Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Payables: 2011-2018

Historic Payables for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Jun 2018 value amounting to $2.9 million.

  • EyePoint Pharmaceuticals' Payables rose 128.91% to $6.3 million in Q1 2019 from the same period last year, while for Mar 2019 it was $16.0 million, marking a year-over-year increase of 127.70%. This contributed to the annual value of $2.9 million for FY2018, which is 189.37% up from last year.
  • According to the latest figures from FY2018, EyePoint Pharmaceuticals' Payables is $2.9 million, which was up 189.37% from $1.0 million recorded in FY2017.
  • In the past 5 years, EyePoint Pharmaceuticals' Payables registered a high of $2.9 million during FY2018, and its lowest value of $464,000 during FY2014.
  • For the 3-year period, EyePoint Pharmaceuticals' Payables averaged around $1.8 million, with its median value being $1.4 million (2016).
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Payables tumbled by 30.85% in 2014 and then skyrocketed by 189.37% in 2018.
  • EyePoint Pharmaceuticals' Payables (Yearly) stood at $464,000 in 2014, then soared by 60.34% to $744,000 in 2015, then surged by 83.20% to $1.4 million in 2016, then fell by 25.46% to $1.0 million in 2017, then soared by 189.37% to $2.9 million in 2018.